📰 Given Genu News
Given Genu News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Given Genu. Real-time updates on events, politics, business and more.
July 3, 2023
Genus (OTCMKTS:GENSF – Free Report) is one of 387 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its competitors? We will compare Genus to similar companies based on the strength of its analyst recommendations, earnings, institutional ownership, risk, dividends, valuation and profitability. Analyst Recommendations This is a summary of […]
June 22, 2023
Genus (OTCMKTS:GENSF – Get Rating) is one of 403 public companies in the “Biotechnology” industry, but how does it weigh in compared to its competitors? We will compare Genus to related businesses based on the strength of its profitability, risk, earnings, dividends, analyst recommendations, institutional ownership and valuation. Earnings and Valuation This table compares Genus […]
June 12, 2023
Genus (OTCMKTS:GENSF – Get Rating) is one of 346 public companies in the “Biotechnology” industry, but how does it weigh in compared to its competitors? We will compare Genus to similar companies based on the strength of its dividends, valuation, earnings, analyst recommendations, risk, profitability and institutional ownership. Valuation & Earnings This table compares Genus […]
June 8, 2023
Genus (OTCMKTS:GENSF – Get Rating) is one of 365 public companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare Genus to related businesses based on the strength of its valuation, risk, analyst recommendations, dividends, institutional ownership, profitability and earnings. Insider and Institutional Ownership 29.7% of Genus […]
June 8, 2023
Genus (OTCMKTS:GENSF – Get Rating) is one of 365 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare Genus to related companies based on the strength of its risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations. Earnings & Valuation This table compares Genus […]